Our results show for the first time the genome-wide transcriptional consequences of PI3K/mTOR pathway and RPS6KB1 inhibitions in breast cancer, suggesting novel downstream targets for PI3K/mTOR pathway and p70S6 kinase. This evidence concerns the gene MTOR and breast carcinoma.